Results 21 to 30 of about 5,487 (231)

Update on Genetic Chorea. [PDF]

open access: yesEur J Neurol
This review provides an updated clinical and genetic framework for the differential diagnosis of hereditary chorea. It guides neurologists through the interpretation of phenomenology, ancillary tests, and appropriate genetic techniques to achieve an accurate and timely diagnosis.
Pérez-Pérez J   +5 more
europepmc   +2 more sources

Case report: Whole exome sequencing identifies a novel variant in the HPRT1 gene in a male with developmental delay [PDF]

open access: yesFrontiers in Genetics
Lesch-Nyhan syndrome (LNS, OMIM #300322) is a rare X-linked genetic disorder caused by variants in the HPRT1 gene, which codes for the Hypoxanthine-guanine phosphoribosyltransferase (HGPRT).
Haoyang Zheng   +24 more
doaj   +2 more sources

Striatal neurodevelopment is dysregulated in purine metabolism deficiency and impacts DARPP-32, BDNF/TrkB expression and signaling: new insights on the molecular and cellular basis of Lesch-Nyhan Syndrome. [PDF]

open access: yesPLoS ONE, 2014
Lesch-Nyhan Syndrome (LNS) is a neurodevelopmental disorder caused by mutations in the gene encoding the purine metabolic enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT).
Ghiabe-Henri Guibinga   +2 more
doaj   +2 more sources

Anaesthetic management of a child with Lesch Nyhan syndrome

open access: yesIndian Journal of Anaesthesia, 2019
Shraya Banerjee   +3 more
doaj   +2 more sources

223 Lesch-Nyhan syndrome: from patient to mouse model [PDF]

open access: greenJ Anim Sci, 2019
Kubekina M   +4 more
europepmc   +3 more sources

Lesch-Nyhan syndrome: case brief of a rare disease [PDF]

open access: diamond, 2018
Lesch-Nyhan Syndrome is a rare X- linked disease due to absence of HPRT enzyme. It leads to hyperuricemia, gout, renal failure, neurological and behavioural disorders, including compulsive self-mutilation. Management includes drugs against hyperuricemia,
Sunil Kumar Agarwalla   +1 more
openalex   +3 more sources

Reduction of self-mutilating behavior and improved oromotor function in a patient with Lesch-Nyhan syndrome following botulinum toxin injection: A case report

open access: yesJournal of Pediatric Rehabilitation Medicine, 2021
Lesch-Nyhan syndrome is a genetic metabolic disorder often involving dystonia and self-mutilating behavior. This case report describes a 13-year-old boy with Lesch-Nyhan syndrome and self-mutilating behavior who received botulinum toxin injections to his
Courtney Gilbert   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy